首页> 外国专利> Variants of the humanized antibody (ba2401), particularly in combination with proto and hemoglobin, increased the medieval half-life, increased the pharmaceutical composition, and were used in the treatment of Alzheimer's and other neurodegenerative diseases

Variants of the humanized antibody (ba2401), particularly in combination with proto and hemoglobin, increased the medieval half-life, increased the pharmaceutical composition, and were used in the treatment of Alzheimer's and other neurodegenerative diseases

机译:人源化抗体的变体(ba2401),特别是与原血红蛋白结合使用,可延长中世纪的半衰期,延长药物成分,并用于治疗阿尔茨海默氏病和其他神经退行性疾病

摘要

p This Invention Bertalanffy refers to the P & eacute; beta Amyloid (a Beta ptido & aacute;) and M & S & amp; specific Antibody; specifically uni Bertalanffy to protofibrillas & beta; and their use in therapy and / or treatment Profil & nbsp Tactical; Alzheimer's disease and other Disorders associated with Agre GACI & amp; n Protein & iacute; na & beta;.The Invention also & nbsp; S Bertalanffy may refer to the Diagnosis & acute; s of such diseases as & nbsp; and monitor the Progress of the disease through the use of the Antibodies of the invention & acute; S & N. in addition, The Invention can Bertalanffy may refer to the veterinary use the Antibodies of The Invention Bertalanffy. / p
机译:本发明Bertalanffy指的是P&eacute; β淀粉样蛋白(一种Beta ptido和autete;)和M&S&amp;特异性抗体;特别是原纤维和beta的uni Bertalanffy;及其在治疗和/或治疗中的用途战术;阿尔茨海默氏病和其他与Agre GACI和AMP相关的疾病n蛋白质&iacute; na&beta;。发明也S Bertalanffy可参考诊断与急性;诸如此类的疾病通过使用本发明的和急性抗体来监测疾病的进展;另外,本发明的Bertalanffy可指兽用的本发明的Bertalanffy的抗体。 < / p>

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号